Clinical characteristics and long-term mortality of patients with midrange ejection fraction undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

28 August 2020 (08:00 - 18:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Jelena Vratonjic

University Clinical Center of Serbia, Belgrade (Serbia)

274 More presentations in this session

Presentation thumbnail

Increased myocardial fat supply improves cardiac energetics and function in heart failure

Doctor W. Watson (Cambridge, GB)

Abstract Slides

Presentation thumbnail

Cardiac aging is regulated by autophagic disorder mediated by chronic inflammation via the Rubicon/NOX4 pathway.

Doctor T. Kamihara (Obu, JP)

Abstract Slides

Presentation thumbnail

Participants with diabetes have less augmentation in cardiac function and energetics in response to increased supply of fatty acid

Doctor P. Green (Hobart, AU)

Abstract Slides

Presentation thumbnail

Impaired high-density lipoprotein function in patients with heart failure

Ms L. Emmens (Groningen, NL)

Abstract Slides

Presentation thumbnail

The comparison of clinical significance between atrial and ventricular structural remodeling in patients with heart failure with preserved ejection fraction - insights from PURSUIT-HFpEF registry

Doctor M. Okada (Osaka, JP)

Abstract Slides

Access the full session

Session thumbnail

Chronic Heart Failure ePosters

The Event

ESC Congress 2020

28 August 2020 08:00 CET

You may be interested in

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Presentation

Audience Q&A

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources